News - Latest

1. Registering the continued use of antimycotics or antiprotozoal veterinary medicinal products exclusively intended for specific companion animals

   Prior to the introduction of the  Veterinary Medicinal Products Regulation, antimycotics (antifungal agents) and antiprotozoal ...

   News item | 29-12-2022 | 12:15

2. Veterinary Medicinal Products Unit Fees for 2023 in revised Veterinary Medicinal Products Regulation 2022

   With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees. The fees of the Veterinary ...

   News item | 29-12-2022 | 12:00

3. New issue of Regulatory Science Magazine

   A significant portion of the potential anticancer medicines that reach the clinical phase do not make it to registration. This is ...

   News item | 07-12-2022 | 14:15

4. Amended procedure for sending, communicating and publishing letters and decisions

   The Veterinary Medicinal Products Unit has set in motion a number of changes to the sending, communicating and publishing letters ...

   News item | 06-10-2022 | 16:30

5. Form for specifying an e-mail address for receipt of digital decisions

   As from 1 October, the Veterinary Medicinal Products Unit will no longer send marketing authorisations in hard copy. We ask all ...

   News item | 16-08-2022 | 10:00

6. Changes to application forms and invitation to participate in the Veterinary Medicines Information Database survey

   The new  Veterinary Medicinal Products Regulation came into force on 28 January 2022. Among many other consequences, this ...

   News item | 27-06-2022 | 11:30

7. All MEB correspondence on human medicines will in future be sent by email

   From 1 July 2022, all correspondence from the Medicines Evaluation Board on human medicines will be sent by email. Correspondence ...

   News item | 24-06-2022 | 16:00

8. MEB Annual Report 2021: Looking ahead

   The coronavirus had a big impact on the year 2021, just like it did in 2020. It made 2021 very special year once again. In the ...

   News item | 10-05-2022 | 11:00

9. Amended policy on national implementation of additional risk minimisation measures

   The Medicines Evaluation Board (MEB) has amended its policy for the national implementation of additional risk minimisation ...

   News item | 30-03-2022 | 15:00

10. Regulatory Science Magazine on academic drug development

    The academic world plays a key role in drug discovery and development. However, bringing drugs to market is challenging and ...

    News item | 24-03-2022 | 16:00